Kent Imaging
Advancing Tissue Assessment
Advancing Tissue Assessment
Kent Imaging is a prominent player in the healthcare industry, specializing in multispectral oxygenation imaging. Founded in 2006, the company is headquartered in Calgary, Alberta, Canada, with additional locations in Chicago, Los Angeles, Salt Lake City, and Seattle. Kent Imaging is dedicated to enhancing patient outcomes through innovative imaging technology tailored to various medical specialties including plastic surgery, colorectal surgery, trauma, wound care, limb salvage, podiatry, burns, and cardiac specialties. The company holds multiple patents in medical technology and is actively engaged in commercializing breakthrough multispectral imaging solutions that assess tissue oxygen saturation. Their commitment to improving healthcare is underpinned by their recent $15.00M Venture Round investment on 12 February 2021, which was secured from TVM Capital Life Science. With a focus on Health Care and Manufacturing industries, Kent Imaging aims to continue leading the way in advancing tissue assessment with its cutting-edge technology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $15.00M | 1 |
|
12 Feb 2021 |
| Grant | $1.10M | 1 | Western Innovation (WINN) Initiative | 20 Nov 2018 |
| Venture Round | Unknown | 1 |
|
01 Jan 2012 |
| Seed Round | Unknown | - | 01 Jan 2006 |
No recent news or press coverage available for Kent Imaging.
We care about your data, and we'd love to use cookies make your experience better.
